The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Telehealth provider Hims & Hers Health is defending its planned Super Bowl ad, which is styled as a political manifesto ...

And last year, the FDA issued warnings about the drugs, but they haven’t been recalled and remain readily available. So, what is going on with compounded semaglutide, and is it safe? How can you tell ...

And last year, the FDA issued warnings about the drugs, but they haven’t been recalled and remain readily available. So, what is going on with compounded semaglutide, and is it safe? How can you tell ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Although the ad does not identify the medication, Hims & Hers offers compounded versions of the weight-loss drug semaglutide, which was developed by Novo Nordisk and is typically sold under the ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D). Current ...

Here’s the short version: Compounded semaglutide isn’t approved by the FDA (U.S. Food and Drug Administration), so it hasn’t been proven effective in clinical trials. However, it contains ...

Semaglutide is the active ingredient in three medications approved by the U.S. Food and Drug Administration (FDA): Ozempic, Rybelsus, and Wegovy. The first two are approved to treat type 2 ...